3.9 Article

Myeloid-derived suppressor-like cells - a potential biomarker for prognosis of colorectal cancer?

Journal

VOJNOSANITETSKI PREGLED
Volume 80, Issue 6, Pages 514-523

Publisher

MILITARY MEDICAL ACAD-INI
DOI: 10.2298/VSP220117083B

Keywords

biomarkers; colorectal neoplasms; myeloid-derived suppressor cells; prognosis; treatment outcome

Ask authors/readers for more resources

The aim of this study was to examine the potential prognostic role of peripheral blood MDSC counts in colorectal cancer (CRC) patients. The results showed that percentages and absolute numbers of CD16(low) granulocytes, as well as the absolute numbers of M-MDSC like cells, the CD16(high)/CD16(low) granulocytes ratio, monocyte/M-MDSC like cells ratio, and NLR ratio, may be reliable indicators of overall survival in CRC patients.
Background/Aim. Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous group of immature cells that have the ability to inhibit both the innate and adaptive immune response. Due to their immunosuppressive effect, MDSCs can promote the growth and progression of cancer. Colorectal cancer (CRC) is one of the most common cancers in the general population for whose advanced stages there is still no successful therapy. In addition to contributing to the development and spread of CRC, MDSCs could potentially be seen as markers of its prognosis. The aim of the study was to examine the potential prognostic role of peripheral blood MDSC counts in CRC patients. Methods. This prospective study analyzed the possibility of using CD16(low) granulocytes and monocytic MDSC (M-MDSC) like cells, as well as neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), CD16(high)/CD16(low) granulocytes ratio, and monocyte-to-M-MDSC like cells ratio, before the start of the treatment, as biomarkers for overall survival (OS) in patients with CRC. The hazard ratio with the corresponding confidence interval of 95% (95% CI) was calculated to evaluate the prognostic role of MDSC in CRC. Results. The analysis was performed in 47 patients with stages III and IV of CRC according to the TNM/AJCC disease classification. Reliable data were obtained from 32 patients. Patient blood samples were taken before the possible start of treatment (surgery, chemotherapy). Increased percentages and absolute values of CD16(low )granulocytes, as well as absolute values of M-MDSC like cells, were associated with shorter OS (p < 0.0066, p < 0.0013, and p < 0.0119, respectively). The relationship between CD16(high)/CD16(low) granulocytes ratio and monocyte/M-MDSC like cells ratio with OS indicated the existence of positive correlations between these parameters, where the higher value of this relationship indicated longer OS of patients (p < 0.0054 and p < 0.0148, respectively). The relationship between OS and NLR showed a statistically significant inverse correlation (p = 0.0349). No statistical significance was found in the relationship between OS and LMR. Conclusion. Percentages and absolute numbers of CD16(low) granulocytes, as well as the absolute numbers of M-MDSC like cells, the CD16(high)/CD16(low) granulocytes ratio, monocyte/M-MDSC like cells ratio, and NLR ratio, may be reliable indicators of OS in patients with CRC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available